%0 Journal Article
%T An amylin analog used as a challenge test for Alzheimer's disease
%A Alexandra Bourlas
%A Devin Steenkamp
%A Gustavo A. Mercier
%A Haihao Zhu
%A James Rosenzweig
%A Maritza D. Essis
%A Martin Farlow
%A Meenakshi Chivukula
%A Neil Kowall
%A Qiushan Tao
%A Robert A. Stern
%A Weiming Xia
%A Yorghos Tripodis
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2017
%R 10.1016/j.trci.2016.12.002
%X Preclinical studies demonstrate the potential of amylin in the diagnosis of Alzheimer's disease (AD). We aimed to lay the foundation for repurposing the amylin analog and a diabetes drug, pramlintide, for AD in humans
%K Alzheimer's disease (AD)
%K Amylin challenge
%K Pramlintide
%K Safety
%K Diagnosis
%K Biomarkers
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424531/